News report 📈 Stocks 🌍 United States

IBEX Reports Record $164.3M Q4 Revenue, Surpassing HealthTech Growth Targets

IBEX posted record Q4 revenue of $164.3 million, fueled by a 15% annual growth rate and successful expansion into AI-driven customer service solutions that are capturing significant market share.

🕐 1 min read

1 assets impacted (Stocks). Net bias: 1 Bullish, 0 Bearish, 0 Neutral. Strongest signal: IBEX ↑ 8/10 (66% confidence).

📊 Affected Assets (1)

IBEX
Bullish 🤖 66%
📅 Short-term 🌍 US · Explicit

IBEX reported record Q4 2026 revenue of $164.3M, 15% full year growth, and achieved multiple AI-driven client wins, surpassing its HealthTech revenue goal.

🎯 Key Takeaways

  • Q4 revenue reached $164.3 million, marking the sixth consecutive quarter of double-digit growth.
  • HealthTech vertical outperformed expectations, growing 42% in Q4 to reach $114 million for the full year.
  • Strategic AI partnership with Sierra AI is successfully driving new client wins and operational efficiency without cannibalizing human agent revenue.

📝 Executive Summary

IBEX delivered a strong fiscal 2026, reporting record fourth-quarter revenue of $164.3 million, a 12% increase that contributed to a 15% full-year growth rate. The company successfully outperformed market expectations by scaling its HealthTech vertical to $114 million and integrating AI-driven agent solutions that are driving new client acquisitions and operational efficiency.

❓ FAQ

How is IBEX integrating AI into its traditional BPO business model?

IBEX has partnered with Sierra AI to deploy AI agents that handle customer interactions, which the company uses as a 'land and expand' strategy to win new clients and subsequently integrate traditional human agent support.